Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Isacson

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Neuroscience|March 1, 1988
Striatal grafts in rats with unilateral neostriatal lesions--II. In vivo monitoring of GABA release in globus pallidus and substantia nigraD J Sirinathsinghji, S B Dunnett, O Isacson, et al.
Neurobiology of Disease|September 25, 1998
A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's diseaseL C Costantini, P Chaturvedi, D M Armistead, et al.
Journal of Neurosurgery|February 1, 1993
Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatumD M Frim, M P Short, W S Rosenberg, et al.
Neuroscience Letters|October 24, 1985
Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitroP Brundin, G Barbin, O Isacson, et al.
Cell Transplantation|March 1, 1996
Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degenerationW R Galpern, D M Frim, S B Tatter, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Cholecystokinin content in the basal ganglia in Huntington's disease. The expression of cholecystokinin immunoreactivity in striatal grafts to ibotenic acid-lesioned rat striatumP C Emson, D Dawbarn, M N Rossor, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Cell-mediated delivery of neurotrophic factors and neuroprotection in the neostriatum and substantia nigraO Isacson, D M Frim, W R Galpern, et al.
Nature Medicine|November 11, 1998
Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson diseaseA L Brownell, B G Jenkins, D R Elmaleh, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the ratD M Frim, T A Uhler, W R Galpern, et al.
Brain Research|January 8, 1986
In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysisT Zetterström, P Brundin, F H Gage, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Neuroscience|March 1, 1988
Striatal grafts in rats with unilateral neostriatal lesions--II. In vivo monitoring of GABA release in globus pallidus and substantia nigraD J Sirinathsinghji, S B Dunnett, O Isacson, et al.
Neurobiology of Disease|September 25, 1998
A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's diseaseL C Costantini, P Chaturvedi, D M Armistead, et al.
Journal of Neurosurgery|February 1, 1993
Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatumD M Frim, M P Short, W S Rosenberg, et al.
Neuroscience Letters|October 24, 1985
Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitroP Brundin, G Barbin, O Isacson, et al.
Cell Transplantation|March 1, 1996
Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degenerationW R Galpern, D M Frim, S B Tatter, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Cholecystokinin content in the basal ganglia in Huntington's disease. The expression of cholecystokinin immunoreactivity in striatal grafts to ibotenic acid-lesioned rat striatumP C Emson, D Dawbarn, M N Rossor, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Cell-mediated delivery of neurotrophic factors and neuroprotection in the neostriatum and substantia nigraO Isacson, D M Frim, W R Galpern, et al.
Nature Medicine|November 11, 1998
Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson diseaseA L Brownell, B G Jenkins, D R Elmaleh, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the ratD M Frim, T A Uhler, W R Galpern, et al.
Brain Research|January 8, 1986
In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysisT Zetterström, P Brundin, F H Gage, et al.
Pageof 15